Viewing Study NCT03535961


Ignite Creation Date: 2025-12-24 @ 12:34 PM
Ignite Modification Date: 2026-01-04 @ 8:24 AM
Study NCT ID: NCT03535961
Status: COMPLETED
Last Update Posted: 2020-12-02
First Post: 2017-09-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer
Sponsor: Chinese Academy of Medical Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module